Your browser has javascript turned off or blocked. This will lead to some parts of our website to not work properly or at all. Turn on javascript for best performance.

The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Default user image.

Pontus Dunér

Assistant researcher

Default user image.

Immune Responses Aginst Aldehyde Modified Extracellular Matrix in Atherosclerosis

Author

  • Pontus Dunér

Summary, in English

Atherosclerosis is a chronic inflammatory disease and the leading cause of myocardial infarction and stroke. Accumulation, aggregation and subsequent oxidation of LDL in the arterial wall are considered as key events in the development of atherosclerosis. The oxidation of LDL generates reactive aldehydes, including malondialdehyde (MDA) that modifies ApoB in LDL. Immune responses against MDA-modified epitopes on ApoB have been shown to be linked to atherosclerotic disease. This thesis is focused on the possibility that LDL oxidation result in the release of MDA that modified surrounding extracellular matrix (ECM) proteins. These modifications may subsequently target immune responses against the plaque ECM and influence the atherosclerotic process. Our studies provide evidence for the presence of MDA-modifications on ECM proteins during atherosclerosis. We also show that antibodies against several MDA-modified ECM proteins are present in human plasma. A prospective clinical study showed that subjects that later suffered from acute cardiovascular events had significantly lower IgG and IgM antibody levels against MDA-modified fibronectin. These epidemiological results indicate that immune responses against MDA-modified fibronectin may have protective effects in atherosclerotic disease. To investigate the functional role of immune responses against modified matrix proteins in atherosclerosis, we immunized Apoe-/- mice with two different MDA-modified matrix proteins to which we had found antibodies in human plasma. MDA-modified fibronectin immunization significantly decreased the atherosclerotic plaque development in both aorta and in subvalvular lesions, while MDA-modified laminin resulted in increased plaque development. Finally we show that injection of Alum, an adjuvant commonly used in vaccines, results in LDL oxidation and aldehyde generation at the injection site.

Department/s

  • Cardiovascular Research - Immunity and Atherosclerosis

Publishing year

2009

Language

English

Publication/Series

Lund University Faculty of Medicine Doctoral Dissertation Series

Volume

2009:86

Document type

Dissertation

Publisher

Department of Clinical Sciences, Lund University

Topic

  • Cardiac and Cardiovascular Systems

Keywords

  • PlaqueMalondialdehydeAtherosclerosisAutoantibodiesExtracellular MatrixFibronectinLamininoxidized LDLT regulatory cellsAlum

Status

Published

Research group

  • Cardiovascular Research - Immunity and Atherosclerosis

Supervisor

  • Jan Nilsson
  • Anna Hultgårdh
  • Eva Bengtsson

ISBN/ISSN/Other

  • ISSN: 1652-8220
  • ISBN: 978-91-86253-74-5

Defence date

9 October 2009

Defence time

13:00

Defence place

Midicinska Klinikens aula, ingång 35, Universitetssjukhuset MAS, Malmö

Opponent

  • Andrew C Newby (Professor)